|

Gamunex-C, 10% Injectable Solution Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Grifols Biologicals, LLC1

Indications

  • Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma1
  • Cancer1

St. Petersburg, Florida1 trial

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Study Site 102

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.